Douglas J. Swirsky

Insider Reports History

Location
Rockville, MD
Signature
/s/ David Sandoval, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Douglas J. Swirsky:

Company Role Class Num Shares Value Price $ Report Date Ownership
MAXCYTE, INC. CHIEF FINANCIAL OFFICER Common Stock 161,811 $208,736 $1.29 13 Aug 2025 Direct
MAXCYTE, INC. CHIEF FINANCIAL OFFICER Employee Stock Option (right to buy) 150,000 14 Mar 2025 Direct
Cellectar Biosciences, Inc. Director Stock option (right to buy) 90,000 14 Feb 2025 Direct

Insider Reports Filed by Douglas J. Swirsky

Symbol Company Period Transactions Value $ Form Type Role Filing Time
MXCT MAXCYTE, INC. 13 Aug 2025 1 +$64,500 4 CHIEF FINANCIAL OFFICER 13 Aug 2025, 19:48
MXCT MAXCYTE, INC. 18 Mar 2025 1 -$22,061 4 CHIEF FINANCIAL OFFICER 20 Mar 2025, 18:08
MXCT MAXCYTE, INC. 14 Mar 2025 2 $0 4 CHIEF FINANCIAL OFFICER 18 Mar 2025, 20:33
CLRB Cellectar Biosciences, Inc. 14 Feb 2025 1 $0 4 Director 18 Feb 2025, 16:07
CLRB Cellectar Biosciences, Inc. 14 Jun 2024 1 $0 4 Director 18 Jun 2024, 17:01
MXCT MAXCYTE, INC. 15 Mar 2024 2 $0 4 CHIEF FINANCIAL OFFICER 19 Mar 2024, 18:18
CLRB Cellectar Biosciences, Inc. 28 Jun 2023 1 $0 4 Director 28 Jun 2023, 18:27
MXCT MAXCYTE, INC. 27 Mar 2023 1 $0 4 Chief Financial Officer 28 Mar 2023, 10:06
MXCT MAXCYTE, INC. 27 Mar 2023 0 $0 3 Chief Financial Officer 28 Mar 2023, 10:03
CLRB Cellectar Biosciences, Inc. 24 Jun 2022 1 $0 4 Director 01 Aug 2022, 18:01
CLRB Cellectar Biosciences, Inc. 14 Sep 2021 1 +$26,000 4 Director 14 Sep 2021, 16:00
CLRB Cellectar Biosciences, Inc. 30 Jun 2021 1 $0 4 Director 02 Jul 2021, 16:04